One Step 10A in vitro diagnostic test
The devices were distributed without required FDA premarket clearance or approval.
The devices were distributed without required FDA premarket clearance or approval.
The devices were distributed without required FDA premarket clearance or approval.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact DFI Co., Ltd. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for DFI Co. recalls
Be the first to know. Free instant alerts to your inbox.
Uric Acid in vitro diagnostic test REF: 31H0P. Reason: The devices were distributed without required FDA premarket clearance or approval.. Classification: Class II. Quantity: 59815 units. Distribution: Worldwide - US Nationwide distribution in the states of FL, PA and the country of England.
Not sure what to do next? Our guide walks you through the process step by step.
Read: How to Get Refunds and ReplacementsGet instant alerts for recalls that affect you. Free forever.
The devices were distributed without required FDA premarket clearance or approval.
The devices were distributed without required FDA premarket clearance or approval.
The devices were distributed without required FDA premarket clearance or approval.
The devices were distributed without required FDA premarket clearance or approval.
The devices were distributed without required FDA premarket clearance or approval.
The devices were distributed without required FDA premarket clearance or approval.